Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

Fundación Cenit Para La Investigación En Neurociencias, CABA

Hospital Británico de Buenos Aires, Ciudad Autónoma de Buenos Aires

Vseobecna fakultni nemocnice v Praze, Prague

INCAN, Mexico City

Sarah Cannon Research Institute - Pharmacy, Nashville

SCRI Oncology Partners, Nashville

START Midwest, Grand Rapids

"Hospital Universitario Dr. Jose Eleuterio Gonzalez", Monterrey

Hospital Reforma, Oaxaca City

Oaxaca Site Management Organization, Oaxaca City

The University of Texas MD Anderson Cancer Center, Houston

Ellison Institute, Los Angeles

Cancer Hospital Chinese Academy of Medical Science, Beijing

Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou

Hubei Cancer Hospital, Wuhan

Henan Cancer Hospital, Zhengzhou

The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an

Smilow Cancer Hospital at Yale - New Haven, New Haven

Yale-New Haven Hospital-Yale Cancer Center, New Haven

Smilow Cancer Hospital Phase 1 Unit, New Haven

Brigham & Women's Hospital, Boston

Dana-Farber Cancer Institute, Boston

Dana Farber Cancer Institute- Chestnut Hill, Newton

Fundación Respirar, Buenos Aires

Clínica Universitaria Reina Fabiola, Córdoba

Fundación CORI para la Investigación y Prevención del Cáncer, La Rioja

Fakultni nemocnice Olomouc, Olomouc

National Cancer Center Hospital East, Kashiwa

Hospital MAC Periferico Sur, Mexico City

COI Centro Oncologico Internacional S.A.P.I. de C.V., Mexico City

Onkologicky ustav sv. Alzbety, s.r.o., Interna klinika VSZaSP a OUSA, Bratislava

Narodny onkologicky ustav, Bratislava

Fakultna nemocnica s poliklinikou Nove Zamky, Nové Zámky

POKO Poprad, s.r.o., Poprad

Cancer Research UK Edinburgh Centre, Edinburgh

St Bartholomew's Hospital, London

Sarah Cannon Research Institute UK, London

The Christie Hospital NHS Foundation Trust, Manchester